This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Theragenics Corporation CEO Discusses Q1 2012 Results - Earnings Call Transcript

Theragenics Corporation (TGX)

Q1 2012 Earnings Call

May 10, 2012 11:00 am ET

Executives



Christine Jacobs - Chairman and Chief Executive Officer

Frank Tarallo – Chief Financial Officer

Analysts

Joe Munda - Sidoti & Company

Rob Longnecker - Joe Street Capital

Presentation

Operator

Greetings and welcome to the Theragenics' First Quarter 2012 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions].

It is now my pleasure to introduce, Ms. Christine Jacobs, Chairman and CEO of Theragenics. Thank you, Ms. Jacobs. You may begin.



Christine Jacobs



Thank you, Claudia. Good morning and welcome to Theragenics' first quarter 2012 conference call. Those of you that join us regularly for these calls will recognize that this conference call will be in a new format, and a little longer than normal.

We met and talked to several of our shareholders this past quarter, and this new format reflects their feedback. Both Frank and I will provide a fresh approach providing both context and insight to the recently completed quarter.

We will also provide strategic positioning and additional forward-looking comments. We're going to spend less time repeating financial information that we assume that you have read or you are going to read in our earnings release that was issued this morning.

This new format is a work-in-progress, which we expect is going to evolve as we progress into 2012. So with that, let me turn it over to Frank for his comments on the first quarter.

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs